Prostate cancer remains one of the most commonly diagnosed malignancies worldwide.
Early diagnosis and curative treatment seem to improve survival in men with unfavourable …

Results The final selected studies (n= 24 studies; 32,715 patients) showed significant
reductions in ICU admission (OR= 0.78, 95% CI: 0.58–1.06; n= 10; I 2= 58.5%) and death …

Importance Targeted magnetic resonance (MR)/ultrasound fusion prostate biopsy has been
shown to detect prostate cancer. The implications of targeted biopsy alone vs standard …

Background Although the use of multiparametric magnetic resonance imaging (mpMRI) in
active surveillance (AS) for prostate cancer is of increasing interest, existing data are derived …

Active surveillance (AS) has been introduced as an observational strategy to delay or avoid
curative treatment without compromising long‐term cancer‐specific survival. The 10 studies …

In the last decade, active surveillance (AS) has emerged as an acceptable choice for low-
risk prostate cancer (PC), however there is discordance amongst large AS cohort studies …

Background Active surveillance (AS) has become a well-accepted and widely used
treatment strategy. Objective To assess the long-term safety of AS for men with screen …

Active surveillance (AS) represents a well-recognized management option for many patients
with low-and very low-risk prostate cancer (PCa). AS aims to reduce overtreatment whilst …

Purpose: Active surveillance to manage prostate cancer provides an alternative to
immediate treatment in men with low risk prostate cancer. We report updated outcomes from …

Objectives Active surveillance (AS), now the standard of care for most men with favourable‐
risk prostate cancer, is appealing for selected men with 'favourable'intermediate‐risk …